SAHPRA Revenue and Competitors
Estimated Revenue & Valuation
- SAHPRA's estimated annual revenue is currently $18.6M per year.
- SAHPRA's estimated revenue per employee is $140,000
Employee Data
- SAHPRA has 133 Employees.
- SAHPRA grew their employee count by 5% last year.
SAHPRA's People
| Name | Title | Email/Phone |
|---|
SAHPRA Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $2.1M | 21 | N/A | N/A | N/A |
#2 | $109.2M | 624 | 23% | N/A | N/A |
#3 | $6.9M | 55 | 6% | N/A | N/A |
#4 | $0.8M | 10 | -9% | N/A | N/A |
#5 | $13.4M | 96 | 5% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $8.6M | 68 | -6% | N/A | N/A |
#8 | $10.6M | 76 | N/A | N/A | N/A |
#9 | $94.5M | 540 | 5% | N/A | N/A |
#10 | $14.4M | 103 | 8% | N/A | N/A |
What Is SAHPRA?
SAHPRA is an entity of the National Department of Health, created by the South African Government to ensure that the health and well-being of human and animal health is at its core. SAHPRA assumed the roles of both the Medicines Control Council (MCC) as well as the Directorate of Radiation Control (DRC) which were housed at the National Department of Health (NDoH). Subsequently, SAHPRA was constituted as an independent entity that reports to the National Minister of Health through its Board.
keywords:N/A
N/A
Total Funding
133
Number of Employees
$18.6M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
SAHPRA News
On 16 April 2022, Windlas Biotech also received certificate of Good Manufacturing Practices (GMP) from SAHPRA (South African Health Products...
Cape Town - The South African Health Products Regulatory Authority (Sahpra) said it would be working with law enforcement to ensure...
CAPE TOWN - The South Africa Health Products Regulatory Authority (SAHPRA) on Friday joined police to investigate claims of hawkers selling...
Other Companies in Pretoria
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $19.4M | 134 | N/A | N/A |
#2 | N/A | 137 | 12% | N/A |
#3 | $28.1M | 142 | 8% | N/A |
#4 | N/A | 149 | 23% | N/A |
#5 | N/A | 153 | 9% | N/A |